-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

905.O3.6 905. Outcomes Research—Lymphoid Malignancies: Outcomes in Lymphoma

Symposia: Outcomes Research—Lymphoid Malignancies Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, adult, Lymphoid Leukemias, Lymphomas, Clinical Practice (Health Services and Quality), epidemiology, CLL, Non-Biological therapies, non-Hodgkin lymphoma, elderly, Clinical Research, health outcomes research, B Cell lymphoma, Combination therapy, T Cell lymphoma, Diseases, indolent lymphoma, patient-reported outcomes, real-world evidence, Therapies, aggressive lymphoma, Lymphoid Malignancies, Adverse Events, survivorship, Study Population, Human
Monday, December 12, 2022: 10:30 AM-12:00 PM
388-390 (Ernest N. Morial Convention Center)
Moderators:
Jean L. Koff, MD, MSc, Emory University and Ning Dong, H. Lee Moffitt Cancer Center and Research Institute
Disclosures:
No relevant conflicts of interest to declare.
This session gives the updates and outcomes in conditions related to lymphoma
10:30 AM

Danny Luan, MD, MPH1, Chen Zhengming, PhD, MPH, MS1*, Lasse Hjort Jakobsen, MSc, PhD2*, Matthew J. Maurer, DSc3, Tarec Christoffer Christoffer El-Galaly, MD, DSc4, Loretta J. Nastoupil, MD5, James R. Cerhan, MD, PhD6, Christopher R. Flowers, MD5, Brian K. Link, MD7, Izidore S. Lossos, MD8, Deborah M. Stephens, DO9, Thomas M. Habermann, MD10, Grzegorz S. Nowakowski, MD11, Nancy L. Bartlett, MD12, Jonathan W. Friedberg, MD, MMSc13, Brad S. Kahl, MD14, John P. Leonard, MD15, Peter De Nully Brown, MD16, Karin E. Smedby, MD, PhD17*, Mats Jerkeman, MD, PhD18 and Peter Martin, FRCPC, MD, MS19

1Weill Cornell Medicine, New York, NY
2Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
3Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN
4Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark
5Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
6Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
7Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
8Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL
9Huntsman Cancer Institute, Salt Lake City, UT
10Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
11Division of Hematology, Mayo Clinic, Rochester, MN
12Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
13James P. Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY
14Division of Oncology, Washington University School of Medicine in St. Louis, Saint Louis, MO
15Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY
16Department of Hematology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
17Karolinska University Hospital, Stockholm, Sweden
18Skane University Hospital and Lund University, Lund, Skaane Laen, Sweden
19Meyer Cancer Center, Weill Cornell Medical College-New York Presbyterian Hospital, New York, NY

10:45 AM

Max J. Gordon, MD1, Zhigang Duan, MS2*, Hui Zhao3*, Loretta J. Nastoupil, MD4, Alessandra Ferrajoli5, Alexey Danilov, MD, PhD6* and Sharon Giordano, MD7*

1University of Texas MD Anderson, Houston
2University of Texas MD Anderson, Texas, TX
3University of Texas MD Anderson Cancer Center, Houston, TX
4Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
6City of Hope National Medical Center, Duarte, CA
7University of Texas MD Anderson, Houston, TX

11:00 AM

Narendranath Epperla, MD, MS1, Rui Li, MPH2*, Pallawi Torka, MD3, Lauren Shea4*, Reem Karmali, MD, MSc5, Andrea Anampa-Guzman, MD3*, Timothy Seijung Oh, MD6*, Kathryn Lindsey, MD7*, Irl Brian Greenwell, MD7, Sayan Mullick Chowdhury, DO, PhD8*, Kaitlin Annunzio, DO9, Beth Christian10, Geoffrey Shouse, PhD, DO11, Alex F. Herrera, MD12, Nancy L. Bartlett, MD13, Natalie S. Grover, MD14 and Adam J. Olszewski, MD15

1The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH
2Division of Hematology, The Ohio State University, Columbus, OH
3Roswell Park Comprehensive Cancer Center, Buffalo, NY
4University of Alabama At Birmingham, Birmingham, AL
5Robert H. Lurie Comprehensive Cancer Center, Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL
6Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
7Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
8Ohio State University Medical Center, Columbus, OH
9The Ohio State University, Columbus, OH
10The Ohio State University Comprehensive Cancer Center, Columbus, OH
11Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
12City of Hope, Duarte, CA
13Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
14Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
15Division of Hematology/Oncology, Brown University, Providence, RI

11:15 AM

Suzanne Neppelenbroek1*, Afke Ekels, MSc2,3*, Marie Jose Kersten, MD, PhD4, Flora Van Leeuwen, Dr. Ir.5*, Djamila E. Issa, MD, PhD6*, Noortje Thielen, MD, PhD7*, Lonneke van de Poll-Franse, PhD8,9,10* and Simone Oerlemans, PhD9*

1Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, Netherlands
2Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, AL, Netherlands
3Department of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Amsterdam, Amsterdam, Netherlands
4Department of Hematology, Academic Medical Center, Amsterdam, Noord Holland, Netherlands
5Department of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, Netherlands
6Department of Hematology, Jeroen Bosch Hospital, Den Bosch, Netherlands
7Department of Internal Medicine, Diakonessenziekenhuis, Utrecht, Netherlands
8Department of Psychosocial Research, Division of Psychosocial Research & Epidemiology, The Netherlands Cancer Institute, Amsterdam, Amsterdam, Netherlands
9Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, Netherlands
10Department of Medical and Clinical Psychology, Tilburg University, Tilburg, Netherlands

11:30 AM

Ryan Jacobs, MD1*, Xiaoxiao Lu, PhD, MD, MPH2*, Bruno Emond, MSc3*, Laura Morrison, MPH3*, Frédéric Kinkead, MA3*, Patrick Lefebvre, MA3*, Marie-Hélène Lafeuille, MA3*, Wasiulla Khan, PhD2*, Linda Wu, PhD2*, Zaina P. Qureshi, PhD, MS, MPH2* and Moshe Yair Levy, MD4

1Hematology, Atrium Health Levine Cancer Institute, Charlotte, NC
2Janssen Scientific Affairs, LLC, Horsham, PA
3Analysis Group, Inc., Montreal, QC, Canada
4Baylor Scott & White Research Institute, Dallas, TX

11:45 AM

Sanjal H Desai, MBBS1,2, Raphael Mwangi, MS3*, Yucai Wang, MD, PhD4, Umar Farooq, MD5, Eric Mou, MD6*, Andrew L. Feldman, MD7, Sergei Syrbu, MD, PhD8*, Susan L. Slager, PhD9, Grzegorz S. Nowakowski, MD2, Matthew J. Maurer, DSc9, Neil E. Kay, MD4, Thomas M. Habermann, MD4, Brian K. Link, MD5, Carrie A. Thompson, MD2 and James R. Cerhan, MD, PhD9

1University of Minnesota, Division of Hematology Oncology Transplantation, Minneapolis, MN
2Division of Hematology, Mayo Clinic, Rochester, MN
3Department of Quantitative Health Sciences Research, Mayo Clinic, Rochester, MN
4Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
5Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
6University of Iowa, Iowa City, IA
7Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
8Department of Pathology, University of Iowa, Iowa City, IA
9Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN

*signifies non-member of ASH